Altogether, knockdown of EZH2 can promote the transcription of FBXL7, which in turn reduced the expression of PFKFB4 protein, thereby inhibiting the glucose metabolism of NSCLC cells, and repressing cell malignant phenotype. Here, EZH2 is linked to non-small cell lung carcinoma.